Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Virtus Biotech Clinical Trials ETF BBC NYSE

NYSE • Financial Services • Asset Management • US • USD

SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Chart & Stats

Market Data
52-Week Range13.42-44.1
Volume13.25K
Avg Volume (30D)19.66K
Market Cap$36.78M
Beta (1Y)1.53
Dividend Yield$0.6554
IPO Date2014-12-17
Financial Highlights & Ratios
Analyst Forecast
Company Info
CountryUS
ExchangeNYSE
CurrencyUSD
ISINUS26923G3011

Price Chart

Track all markets on TradingView
BBC
Virtus Biotech Clinical Trials ETF  ·  NYSE
Financial Services • Asset Management
13.42 52WK RANGE 44.10

People Also View

FBT
FBT
First Trust NYSE Arca Biotechnology Index Fund
$208.68
-0.04%
 SBIO
SBIO
ALPS Medical Breakthroughs ETF
$56.67
+0.91%
 BBP
BBP
Virtus LifeSci Biotech Products ETF
$87.08
-0.06%
 BTEC
BTEC
Principal Healthcare Innovators ETF
$39.49
+1.02%
 CNCR
CNCR
Loncar Cancer Immunotherapy ETF
$9.02
+1.58%
 VITSX
VITSX
Vanguard Total Stock Market Index Fund Institutional Shares
$166.82
+1.15%
 VTSAX
VTSAX
Vanguard Total Stock Market Index Fund Admiral Shares
$166.79
+1.15%
 VSMPX
VSMPX
Vanguard Total Stock Market Index Fund Institutional Plus Shares
$312.93
+1.15%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message